Persephone
Founded 2017 · 16 employees on LinkedIn · 4 known investors
Persephone develops a synbiotic supplement for infants that combines probiotics (keystone Bifidobacterium strains) with prebiotics found in human breast milk to replenish gut bacteria linked to digestion, immunity, and development. The product was developed by microbiome scientists and pediatricians and validated in a clinical study.
Founders & leadership
Persephone was founded in 2017 by Stephanie Culler and Steve Van Dien.
SC
Stephanie CullerCEO & Co-Founder
SV
Steve Van DienCTO & Co-Founder
Investors · 4
Competitors · 3
by search overlapPeople Science4 shared keywordsPeople Science runs real-world clinical research for the health and wellness industry, offering a decentralized clinical trial platform (Chloe Clinical) and a real-world data collection tool (Chloe LiveLab) alongside clinical research services. It serves wellness product companies and innovators seeking evidence for their products through trials, biomarker sampling, and wearables integration.
Persephone Biosciences4 shared keywordsPersephone Biosciences develops a synbiotic (probiotic and prebiotic combination) supplement for infants designed to replenish key beneficial gut bacteria. The product targets parents seeking to support their babies' digestive health, immune development, and overall microbiome health.
Nutraceuticalsworld4 shared keywordsNutraceuticals World is a trade media outlet publishing industry news, market analysis, feature articles, research, and supplier information for the nutraceutical and dietary supplement sector. It also provides resources such as buyer's guides, whitepapers, eBooks, webinars, videos, and event coverage for industry professionals.
Companies competing with Persephone for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Persephone do?
- Persephone develops a synbiotic supplement for infants that combines probiotics (keystone Bifidobacterium strains) with prebiotics found in human breast milk to replenish gut bacteria linked to digestion, immunity, and development. The product was developed by microbiome scientists and pediatricians and validated in a clinical study.
- Who founded Persephone?
- Persephone was founded by Stephanie Culler, Steve Van Dien in 2017.
- Who are Persephone's investors?
- Persephone's investors include First Bight Ventures, Propel Bio Partners, Fifty Years, Y Combinator.